Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model

Author： Umemura K. Ishiye M. Kosuge K. Nakashima M.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.275, Iss.1, 1995-02, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The selective endothelin ET A receptor antagonist FR139317 inhibits neointimal thickening in the rat

By Takiguchi Y. Sogabe K.

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

Tissue-type plasminogen activator as a therapeutic target in stroke

By Gravanis Iordanis Tsirka Stella E

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 159-170

Informa Healthcare

Access to resources Recommend Favorite

Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model

By Terai K. Suzuki M. Sasamata M. Yatsugi S.-i. Yamaguchi T. Miyata K.

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 95-101

Elsevier

Access to resources Recommend Favorite

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

By Lebeurrier Nathalie Vivien Denis Ali Carine

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 309-320

Informa Healthcare

Access to resources Recommend Favorite

Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator

By Uesugi Yoshiko Kawata Hiroyuki Saito Yoshihiko Tabata Yasuhiko

Journal of Drug Targeting, Vol. 20, Iss. 3, 2012-04 ,pp. : 224-234

Informa Healthcare

Access to resources Recommend Favorite